Rapid test BIOSYNEX COVID-19 BSS

Rapid test for qualitative identification of antibodies (IgG and IgM) against SARS-CoV-2 in whole blood, blood serum or plasma. For professional in vitro diagnostics only!
Swiss quality
Rapid result
Result precision – up to 99%
Video demonstration
unnamed-min.jpg
unnamed-9-min.jpg
unnamed-8-min.jpg
unnamed-7-min.jpg
unnamed-6-min.jpg
unnamed-5-min.jpg
unnamed-3-min.jpg
unnamed-2-min.jpg
unnamed-1-min.jpg
Previous
Next
Interpretation of results

POSITIVE RESULT OF IgG and IgM TEST: *Three lines appear.

One colored line has to be located at the area of control line (C), and two colored lines have to appear at the area of the IgG test line and the IgM test line. The line color intensity does not have to coincide. The result is deemed positive for IgG and IgM antibodies, and is indicative of SARS-COV-2 secondary infection.

POSITIVE RESULT OF IgG TEST: *Two lines appear.

One colored line has to be located at the area of control line (C), and another colored line appears in the area of the IgG test line. The result is deemed positive for IgG, specific for SARS-COV-2 virus, and is probably indicative of SARS-COV-2 secondary infection.

POSITIVE RESULT OF IgM TEST: * Two lines appear.

One colored line has to be located at the area of control line (C), and another colored line appears in the area of the IgM test line. The result is deemed positive for IgM, specific for SARS-COV-2 virus, and is probably indicative of SARS-COV-2 primary infection.

NEGATIVE RESULT: One colored line has to be located at the area of control line (C)

No line is displayed at the area of test lines IgG and IgM.

*REMARK: The color intensity in the area of IgG and/or IgM test lines may vary depending on the concentration of SARS-COV-2 antibodies in the sample. That is why any color tint in the area of IgG and/or IgM test line(s) should be deemed a positive result.
Detailed instruction
BIOSYNEX COVID-19 BSS
Rapid test for qualitative identification of antibodies (IgG and IgM) against SARS-CoV-2 in whole blood, blood serum or plasma. For professional in vitro diagnostics only!
Order a consultation
About the manufacturer’s company
A Swiss company BIOSYNEX SWISS SA develops, manufactures and distributes rapid diagnostic tests (RDT) for screening and diagnostics in France and abroad.
These easy-to-use RDT tests allow improving medical care of patients due to rapidness of their results and ease of use.
Contacts
Contacts